Angelo Baccala, Urologist | Pennsylvania
I think the evidence is very clear and has shown that the Prolaris test has the best data...
Brian Richardson, Urologist Alabama
The cell cycle progression that Prolaris offers me gives me something that’s more tumor specific to that patient’s actual cancer.
Ashleigh Renitsky, Oncology PA Pennsylvania
I think in this day and age where people like everything to be tailored to them specifically, Prolaris enables us to do that with cancer treatment.
David Morris, Urologist Tennessee
If you line up 10 guys you can’t pick the one that may have a problem. Even if they have the exact same PSA and Gleason Score, genetics tells a bigger picture behind the scenes.
Mark Edney, Urologist Maryland
Historically, we’ve had to aggressively treat a lot of indolent disease that we know probably weren’t destined to progress. That all has changed with genetic and genomic testing.
Tim Richardson, Urologist Kansas
Prolaris is very helpful with preventing over treating in some of these patients, especially with the intensification of treatment.
Robert Jansen, Urologist South Carolina
The latest Prolaris report has a great layout. I’m very happy with it. It’s important to me to be able to explain a test report to a patient.
David Rich, Urologist South Carolina
I find the utility for Prolaris most helpful in the patients with low risk or immediate risk prostate cancer.
Barry Zisholtz, Urologist Georgia
Before the Prolaris test came about, we were taking out prostates in almost everybody who was diagnosed with prostate cancer. Studies have shown that some patients who had their prostates taken out may not have needed them taken out.
Get connected with your Myriad Account Executive to learn how Prolaris is personalizing prostate cancer care.